Efficacy and side effects of intermittent recombinant interferon‐α2a in chronic aggressive hepatitis C: With or without initial daily administration
暂无分享,去创建一个
H. Itoh | S. Nishioka | K. Higashi | H. Miyamoto | T. Yamanishi | J. Kawai | Y. Yokoya | H. Nakata | S. Nakashima | T. Yamanishi | T. Hara | Shoichi Nakashima | Hisao Miyamoto